Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E. Y. Karpenko
Efficacy of Target Therapy With Crizotinib in a Patient With Alk-Positive Advanced Gastric Cancer
Siberian Journal of Oncology
Cancer Research
Oncology
Related publications
Crizotinib-Associated Toxic Epidermal Necrolysis in an ALK-positive Advanced NSCLC Patient
Molecular and Clinical Oncology
Cancer Research
Oncology
Efficacy and Safety of Crizotinib Among Chinese EML4-ALK-Positive, Advanced-Stage Non-Small Cell Lung Cancer Patients
PLoS ONE
Multidisciplinary
Dramatic Response to Crizotinib in an ALK-Positive Adenocarcinoma Patient With Disseminated Intravascular Coagulation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Dramatic Response to Crizotinib in a Non–Small-Cell Lung Cancer Patient With IHC-Positive and FISH-Negative ALK
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Outcomes of ALK Positive Lung Cancer Patients Treated With Crizotinib or Second-Generation ALK Inhibitor: A Monoinstitutional Experience
Oncotarget
Oncology
P1.01-45 Crizotinib Efficacy in ALK-Positive Advanced Stage Non-Small Cell Lung Cancer Patients: A Real-World Experience From Turkey
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Case Report of an EML4-ALK-positive Elderly Non-Small Cell Lung Cancer Patient With a Poor PS Successfully Treated With Crizotinib
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
P2.01-109 Treatment Duration—A More Reasonable Definition to Evaluate the Efficacy of Crizotinib in ALK Positive Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Efficacy of Paclitaxel and S-1 in a Patient With Advanced Pseudomyxoma Peritonei Concomitant With Gastric Cancer
General Medicine: Open Access